跳至主要内容
临床试验/NCT01113229
NCT01113229终止4 期

Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 1,721 人开始时间: 2010年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
1,721
试验地点
1
主要终点
Occurrence of post partum hemorrhage > 500mL in 1 hour

研究概览

简要总结

To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks.

详细描述

Objective :

To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks'.

Method :

Double blinded Randomized controlled trial in two centers over 30 months.

Treatment :

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women>18 years,
  • during first stage of normal labor,
  • at 36 to 42 weeks,
  • with epidural analgesia and informed signed consent

排除标准

  • Cesarean section delivery,
  • clotting disorders,
  • prostaglandin allergy,
  • absent consent.

研究组 & 干预措施

Misoprostol

Experimental

10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two misoprostol tablets taken orally (400µg) following cord clamp

干预措施: Misoprostol (Drug)

PLACEBO

Placebo Comparator

10 UI of oxytocin IV during delivery of the anterior shoulder of the newborn and two placebo tablets taken orally following cord clamp.

干预措施: Misoprostol (Drug)

结局指标

主要结局

Occurrence of post partum hemorrhage > 500mL in 1 hour

时间窗: 1 HOUR

次要结局

  • Occurrence of post partum hemorrhage > 1000mL in 1 hour(1 HOUR)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验